Remove 2027 Remove Competition Remove Prospecting
article thumbnail

Sales Strategy For Milk Products Insights

Contrarian Sales Techniques

By focusing on the benefits, you are more likely to make a strong emotional connection with your prospects, which can lead to a sale. This is what sets your product apart from the competition and gives your customers a reason to choose your product over others. billion by 2027, growing at a CAGR of 7.7% from 2020 to 2027.

article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

Results from this trial are scheduled to be released in October 2027, and may allow non-diabetic obese patients to have access to Mounjaro. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Medical 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

Results from this trial are scheduled to be released in October 2027, and may allow non-diabetic obese patients to have access to Mounjaro. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Medical 98
article thumbnail

10 Home Security Sales Tips You’ve Probably Never Tried

Spotio

billion by 2027—a 48% jump from where the industry was last year, in 2022. Your value proposition should be something like, “We offer customers the peace of mind they crave at a lower price point than the competition.” Because stories help sales reps like yourself build personal connections with their prospects.

Sales 40
article thumbnail

Pliant snags $287.5 million in oversubscribed public offering amid market uncertainty

Pharmaceutical Technology

A Pliant spokesperson said, “This successful transaction, along with existing cash, cash equivalents, loan agreement and short-term investments, provides for operations to be funded to mid-2027, a year past the expected IPF Phase 2b clinical trial readout.” The company said a Phase IIb trial initiation should be expected in mid-2023.

article thumbnail

Empress Therapeutics emerges with $50m to fund small molecule development

Pharmaceutical Technology

Analysts forecast the biologics market to be worth $120 billion more than small molecules by 2027. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Leads 52
article thumbnail

Covid-19 vaccine success bolsters nanoparticle drug delivery research

Pharmaceutical Technology

GlobalData predicts that Comirnaty’s sales will increase by more than 20% between 2024 and 2027. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.